Oncologic Significance of Therapeutic Delays in Patients With Oral Cavity Cancer.

Importance Oral cavity cancer often requires multidisciplinary management, subjecting patients to complex therapeutic trajectories. Prolonged treatment intervals in oral cavity cancer have been associated with poor oncological outcomes, but there has yet to be a study investigating treatment times in Canada. Objective To report treatment delays for patients with oral cavity cancer in Canada and evaluate the outcomes of treatment delays on overall survival. Design, Setting, and Participants This multicenter cohort study was performed at 8 Canadian academic centers from 2005 to 2019. Participants were patients with oral cavity cancer who underwent surgery and adjuvant radiation therapy. Analysis was performed in January 2023. Main Outcomes and Measures Treatment intervals evaluated were surgery to initiation of postoperative radiation therapy interval (S-PORT) and radiation therapy interval (RTI). The exposure variables were prolonged intervals, respectively defined as index S-PORT greater than 42 days and RTI greater than 46 days. Patient demographics, Charlson Comorbidity Index, smoking status, alcohol status, and cancer staging were also considered. Univariate (log rank and Kaplan-Meier) and multivariate (Cox regression) analyses were performed to determine associations with overall survival (OS). Results Overall, 1368 patients were included; median (IQR) age at diagnosis was 61 (54-70) years, and 896 (65%) were men. Median (IQR) S-PORT was 56 (46-68) days, with 1093 (80%) patients waiting greater than 42 days, and median (IQR) RTI was 43 (41-47) days, with 353 (26%) patients having treatment time interval greater than 46 days. There were variations in treatment time intervals between institutions for S-PORT (institution with longest vs shortest median S-PORT, 64 days vs 48 days; η2 = 0.023) and RTI (institution with longest vs shortest median RTI, 44 days vs 40 days; η2 = 0.022). Median follow-up was 34 months. The 3-year OS was 68%. In univariate analysis, patients with prolonged S-PORT had worse survival at 3 years (66% vs 77%; odds ratio 1.75; 95% CI, 1.27-2.42), whereas prolonged RTI (67% vs 69%; odds ratio 1.06; 95% CI, 0.81-1.38) was not associated with OS. Other factors associated with OS were age, Charlson Comorbidity Index, alcohol status, T category, N category, and institution. In the multivariate model, prolonged S-PORT remained independently associated with OS (hazard ratio, 1.39; 95% CI, 1.07-1.80). Conclusions and Relevance In this multicenter cohort study of patients with oral cavity cancer requiring multimodal therapy, initiation of radiation therapy within 42 days from surgery was associated with improved survival. However, in Canada, only a minority completed S-PORT within the recommended time, whereas most had an appropriate RTI. An interinstitution variation existed in terms of treatment time intervals. Institutions should aim to identify reasons for delays in their respective centers, and efforts and resources should be directed toward achieving timely completion of S-PORT.

[1]  R. Gilbert,et al.  Association of Household Income at Diagnosis With Financial Toxicity, Health Utility, and Survival in Patients With Head and Neck Cancer. , 2022, JAMA otolaryngology-- head & neck surgery.

[2]  Ryan K. Orosco,et al.  Quality improvement intervention to reduce time to postoperative radiation in head and neck free flap patients , 2021, Head & neck.

[3]  A. Alberg,et al.  Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer , 2021, JCO oncology practice.

[4]  B. Plaat,et al.  To what extent has the last two decades seen significant progress in the management of older patients with head and neck cancer? , 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[5]  W. King,et al.  Mortality due to cancer treatment delay: systematic review and meta-analysis , 2020, BMJ.

[6]  B. Egleston,et al.  Patterns of Multidisciplinary Care of Head and Neck Squamous Cell Carcinoma in Medicare Patients. , 2020, JAMA otolaryngology-- head & neck surgery.

[7]  A. Alberg,et al.  Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer. , 2020, JCO oncology practice.

[8]  Kevin J. Sykes,et al.  What is the hold up?—Mixed‐methods analysis of postoperative radiotherapy delay in head and neck cancer , 2020, Head & neck.

[9]  G. Warren,et al.  Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review , 2019, JAMA otolaryngology-- head & neck surgery.

[10]  D. Schreiber,et al.  The impact of adjuvant chemoradiotherapy timing on survival of head and neck cancers , 2018, The Laryngoscope.

[11]  A. Ho,et al.  Quantitative survival impact of composite treatment delays in head and neck cancer , 2018, Cancer.

[12]  E. Rosenthal,et al.  Reducing the Time from Surgery to Adjuvant Radiation Therapy: An Institutional Quality Improvement Project , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[13]  Ryan K. Orosco,et al.  Association of Time between Surgery and Adjuvant Therapy with Survival in Oral Cavity Cancer , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[14]  T. Day,et al.  Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer , 2017, Cancer.

[15]  A. Rademaker,et al.  National evaluation of multidisciplinary quality metrics for head and neck cancer , 2017, Cancer.

[16]  T. Day,et al.  Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer , 2017, Cancer.

[17]  W. Yarbrough,et al.  Treatment delays in oral cavity squamous cell carcinoma and association with survival , 2017, Head & neck.

[18]  B. Judson,et al.  Treatment delay and facility case volume are associated with survival in early‐stage glottic cancer , 2017, The Laryngoscope.

[19]  T. Yen,et al.  Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma. , 2017, European journal of cancer.

[20]  R. Mehra,et al.  The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer. , 2016, International journal of radiation oncology, biology, physics.

[21]  D. Flieder,et al.  Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  T. Yen,et al.  Association between multidisciplinary team care approach and survival rates in patients with oral cavity squamous cell carcinoma , 2016, Head & neck.

[23]  D. Flieder,et al.  Increasing time to treatment initiation for head and neck cancer: An analysis of the National Cancer Database , 2015, Cancer.

[24]  J. Dewar,et al.  Impact of multidisciplinary team management in head and neck cancer patients , 2011, British Journal of Cancer.

[25]  J. Cooper Ajcc Cancer Staging Manual , 1997 .